• New Launches

Novo Nordisk India launches world’s first and only GLP-1 RA, Oral Semaglutide- a gamechanger in diabetes

Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), indicated for the management of type 2 diabetes has been developed in an…